Literature DB >> 16420205

Comorbidity profile of dementia patients in primary care: are they sicker?

Cathy C Schubert1, Malaz Boustani, Christopher M Callahan, Anthony J Perkins, Caroline P Carney, Christopher Fox, Frederick Unverzagt, Siu Hui, Hugh C Hendrie.   

Abstract

OBJECTIVES: To compare the medical comorbidity of older patients with and without dementia in primary care.
DESIGN: Cross-sectional study.
SETTING: Wishard Health Services, which includes a university-affiliated, urban public hospital and seven community-based primary care practice centers in Indianapolis. PARTICIPANTS: Three thousand thirteen patients aged 65 and older attending seven primary care centers in Indianapolis, Indiana. MEASUREMENTS: An expert panel diagnosed dementia using International Classification of Diseases, 10th Revision, criteria. Comorbidity was assessed using 10 physician-diagnosed chronic comorbid conditions and the Chronic Disease Score (CDS).
RESULTS: Patients with dementia attending primary care have on average 2.4 chronic conditions and receive 5.1 medications. Approximately 50% of dementia patients in this setting are exposed to at least one anticholinergic medication, and 20% are prescribed at least one psychotropic medication. After adjusting for patients' age, race, and sex, patients with and without dementia have a similar level of comorbidity (mean number of chronic medical conditions, 2.4 vs 2.3, P=.66; average CDS, 5.8 vs 6.2, P=.83).
CONCLUSION: Multiple medical comorbid conditions are common in older adults with and without dementia in primary care. Despite their cholinergic deficit, a substantial proportion of patients with dementia are exposed to anticholinergic medications. Models of care that incorporate this medical complexity are needed to improve the treatment of dementia in primary care.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16420205     DOI: 10.1111/j.1532-5415.2005.00543.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  95 in total

1.  Implementing innovative models of dementia care: The Healthy Aging Brain Center.

Authors:  Malaz A Boustani; Greg A Sachs; Catherine A Alder; Stephanie Munger; Cathy C Schubert; Mary Guerriero Austrom; Ann M Hake; Frederick W Unverzagt; Martin Farlow; Brandy R Matthews; Anthony J Perkins; Robin A Beck; Christopher M Callahan
Journal:  Aging Ment Health       Date:  2011-01       Impact factor: 3.658

2.  Can primary care meet the biopsychosocial needs of older adults with dementia?

Authors:  Malaz Boustani; Greg Sachs; Christopher M Callahan
Journal:  J Gen Intern Med       Date:  2007-09-20       Impact factor: 5.128

3.  A preliminary study of anticholinergic burden and relationship to a quality of life indicator, engagement in activities, in nursing home residents with dementia.

Authors:  Ann Kolanowski; Donna M Fick; Judy Campbell; Mark Litaker; Malaz Boustani
Journal:  J Am Med Dir Assoc       Date:  2009-01-09       Impact factor: 4.669

4.  The Effects of Age, Mental Health, and Comorbidity on the Perceived Likelihood of Hiring a Healthcare Advocate.

Authors:  Symone A McKinnon; Breanna M Holloway; Maya S Santoro; April C May; Terry A Cronan
Journal:  Calif J Health Promot       Date:  2016

5.  State of Science: Bridging the Science-Practice Gap in Aging, Dementia and Mental Health.

Authors:  Christopher M Callahan; Daniel R Bateman; Sophia Wang; Malaz A Boustani
Journal:  J Am Geriatr Soc       Date:  2018-04       Impact factor: 5.562

Review 6.  Integrating care for older adults with cognitive impairment.

Authors:  Christopher M Callahan; Malaz Boustani; Greg A Sachs; Hugh C Hendrie
Journal:  Curr Alzheimer Res       Date:  2009-08       Impact factor: 3.498

7.  The relationship between anticholinergic medications and Mini-Cog scores in older adults receiving home health care.

Authors:  Susan L Lakey; Peggy S Odegard; Travis E Sonnett; Stephen M Setter; Soo Borson
Journal:  Consult Pharm       Date:  2009-09

8.  Charlson Comorbidity Index, inappropriate medication use and cognitive impairment : Bermuda Triangle.

Authors:  Kamile Silay; Ahmet Yalcin; Sema Akinci; Fatma Gul Gursoy; Didem Sener Dede
Journal:  Wien Klin Wochenschr       Date:  2017-09-01       Impact factor: 1.704

Review 9.  Risk factors for the progression of mild cognitive impairment to dementia.

Authors:  Noll L Campbell; Fred Unverzagt; Michael A LaMantia; Babar A Khan; Malaz A Boustani
Journal:  Clin Geriatr Med       Date:  2013-11       Impact factor: 3.076

10.  Thyroid hormone status and health-related quality of life in the LifeLines Cohort Study.

Authors:  Elise I Klaver; Hannah C M van Loon; Riejanne Stienstra; Thera P Links; Joost C Keers; Ido P Kema; Anneke C Muller Kobold; Melanie M van der Klauw; Bruce H R Wolffenbuttel
Journal:  Thyroid       Date:  2013-09       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.